META vs NKE: Which Is the Better Buy?

Side-by-side comparison of Meta Platforms, Inc. and NIKE, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-11.
Meta Platforms, Inc. Β· Communication Services
$611.40
+12.9% upside to fair value
High Conviction Grade A-
VS
NIKE, Inc. Β· Consumer Cyclical
$42.62
+45.5% upside to fair value
Med Conviction Grade B+
QuantHub Verdict
NKE has more upside to fair value (+45.5%). META trades at a lower forward P/E (23.0x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric META NKE
Current Price $611.40 $42.62
Fair Value Estimate $690.00 $62.00
Upside to Fair Value +12.9% +45.5%
Market Cap $1,541.3B $63.0B
Forward P/E 23.0x 27.9x
EV / EBITDA 18.0x 20.7x
Price / Sales 7.7x 1.4x
Price / FCF 33.4x 19.4x
Revenue Growth YoY +22.2% -9.8%
Gross Margin 82.0% 42.7%
Operating Margin 41.4% 8.0%
Return on Equity 30.6% 24.4%
Dividend Yield 0.4% 3.8%
FCF Yield 3.0% 5.2%
Analyst Consensus Strong Buy Buy
Investment Thesis
META β€” Meta Platforms, Inc.
Meta Platforms operates the world's largest social media ecosystem (Facebook, Instagram, WhatsApp, Threads) reaching 3.3B+ daily users, generating $201B in revenue predominantly from digital advertising. The company's 82% gross margins and AI-powered ad targeting create an extraordinarily profitable core business. Trading at its 5-year P/E low of 25.5x despite 22% revenue growth, META is cheap on…
NKE β€” NIKE, Inc.
Nike is the world's largest athletic footwear and apparel company with $46.3B in FY2025 revenue, operating across 190+ countries with the Nike, Jordan, and Converse brands. The stock trades near its 9-year low at $42.62 after an 11% single-day crash following a Q3 FY2026 earnings report that showed 35% net income decline and weak Q4 guidance calling for a further 2-4% revenue decline. FY2025 reve…
Accumulation Zones
Metric META NKE
Zone Low $520.00 $44.00
Zone High $590.00 $50.00
In Buy Zone? No Yes
← META Research    NKE Research β†’    All Research